Antibody studies of factor VIII inhibitor in a case with Waldenstrom's macroglobulinemia

American Journal of Hematology

Volumn 63, Issue 3, 2000, Pages 145-148

  Endo, Takeshi ^a   Yatomi, Yutaka ^b   Amemiya, Norihiko ^a   Mizoe, Asako ^a   Iino, Masaki ^c   Ozawa, Hideyuki ^d   Hosogaya, Shigemi ^a   Ozaki, Yukio ^b  

^a YAMANASHI PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c Yokkaichi Municipal Hospital   (Japan)

^d Koshimizu Red Cross Hospital   (Japan)

Author keywords

Anticoagulant; Factor VIII; Waldenstrom's macroglobulinemia

Indexed keywords

BLOOD CLOTTING FACTOR 8 ANTIBODY; BLOOD CLOTTING FACTOR 8 INHIBITOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G ANTIBODY; PARAPROTEIN; POLYCLONAL ANTIBODY; RECOMBINANT BLOOD CLOTTING FACTOR 8;

AGED; ANTIBODY TITER; ANTICOAGULATION; ARTICLE; BLEEDING TENDENCY; CASE REPORT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PARTIAL THROMBOPLASTIN TIME; PLASMA; PLASMAPHERESIS; PRIORITY JOURNAL; WALDENSTROEM MACROGLOBULINEMIA;

AGED; AUTOANTIBODIES; BLOOD COAGULATION DISORDERS; EPITOPES; FACTOR VIII; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; KINETICS; MALE; WALDENSTROM MACROGLOBULINEMIA;

EID: 0034003168     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(200003)63:3<145::AID-AJH7>3.0.CO;2-E     Document Type: Article

References (12)

1. Kipps TJ. Macroglobulinemia. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, editors. Williams hematology. New York: McGraw-Hills; 1995. p 1127-1132.
2. Roberts HR, Eberst ME. Other coagulation factor deficiencies. In: Loscalzo J, Schafer AI, editors. Thrombosis and hemorrhage. Boston: Blackwell Scientific Publications; 1994. p 701-728.
3. Glaspy JA. Hemostatic abnormalities in multiple myeloma and related disorders. Hematol Oncol Clin N Am 1992;6:1301-1314.
4. Thiagarajan P, Shapiro SS, De Marco L. Monoclonal immunoglobulin M λ coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant. J Clin Invest 1980;66:397-405.
5. Kasper CK, Aledort L, Aronson D, Counts R, Edson JR, van Eys J, Fratantoni J, Green D, Hampton J, Hilgartner M, Levine P, Lazerson J, McMillan C, Penner J, Shapiro S, Shulman NR. Proceedings: A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975;34:612.
6. Biggs R, Austen DE, Denson KW, Rizza CR, Borrett R. The mode of action of antibodies which destroy factor VIII. I. Antibodies which have second-order concentration graphs. Br J Haematol 1972;23:125-135.
7. Biggs R, Austen DE, Denson KW, Borrett R, Rizza CR. The mode of action of antibodies which destroy factor VIII. II. Antibodies which give complex concentration graphs. Br J Haematol 1972;23:137-155.
8. Fulcher CA, de Graaf Mahoney S, Roberts JR, Kasper CK, Zimmerman TS. Localization of human factor FVIII inhibitor epitopes to two polypeptide fragments. Proc Natl Acad Sci USA 1985;82:7728-7732.
9. Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemostas 1981;45:200-203.
10. Castaldi PA, Penny R. A macroglobulin with inhibitory activity against coagulation factor VIII. Blood 1970;35:370-376.
11. Hoyer LW, Gawryl MS, de la Fuente B. Immunochemical characterization of factor VIII inhibitors. In: Hoyer LW, editor. Factor VIII inhibitors. New York: Alan R Liss; 1984. p 73-85.
12. Lollar P, Parker ET, Curtis JE, Helgerson SL, Hoyer LW, Scott ME, Scandella D. Inhibition of human factor VIIIa by anti-A2 subunit antibodies. J Clin Invest 1994;93:2497-2504.